The battle of high drug pricing is one that big pharma risks losing

ways-retirees-can-save-cost-prescription-drugs1Evidence of recent weeks suggests that the battle of high drug pricing is one that big pharma risks losing, raising questions over the economic model of an industry that relies heavily on US profits to reward investors and finance new drugs. Pharmaceutical executives say their ability to price drugs in the US, according to what the market will bear allows them to cover the considerable cost of finding new, often revolutionary, treatments; the cost of developing and winning approval for a new drug now runs at $2.6bn, according to the Tufts Center for the Study of Drug Development, compared with $802m in 2003. Continue reading »

I lost my best friend…

screenshot_180Perhaps the way to truly demonstrate problems with our health care system is to share personal stories about failures of living in what some say “is the best healthcare system” in the world.  This is a story of my friend Pete and I urge you to read and share this story so others might learn and understand that we still have a long way to go. Continue reading »

Time to rethink drug websites

THINK Road SignPOST SUMMARY: Google graph for health is a game changer for online health and while it needs to be watched to determine its impact on drug.com websites DTC digital marketers should start to optimize their websites for both patients and ROI. Continue reading »

Did Google just make health information on pharma websites obsolete?

logo11wPOST SUMMARY: Google searches for certain medical conditions will now bring up typical symptoms and treatments, along with details about how common the condition is. All answers are compiled, curated, and reviewed by a team of medical doctors at Google and the Mayo Clinic, using a combination of clinical knowledge and high-quality medical sources across the Internet. Continue reading »

How should pharma respond when attacked?

largePOST SUMMARY: John Oliver took on big pharma, breaking down exactly how pharmaceutical companies spend a fortune ($24 billion just last year) marketing directly to doctors.  It’s been going viral on the Web, so how should pharma respond? Continue reading »

The FDA on print ads…

horse-cart-450x298POST SUMMARY: The FDA is planning to make it easier for consumers to understand complicated language in print ads and while this is a good first step they need to better understand how DTC ads are actually leading to healthcare decisions. Continue reading »

Our healthcare system is still broken

broken_by_liebe_siePOST SUMMARY: Drug marketers may be wasting a lot of money trying to drive demand for their products because the current healthcare system is getting harder to navigate and it’s making it harder for patients to be “consumers of healthcare. Continue reading »

Failure to take medications costs over $300 billion annually

Medical experts estimate that the failure to take prescription medications as directed costs some $300 billion a year in emergency room visits, in patient hospital care and extra visits to physicians offices.  If you think it’s all due to drug costs think again.  One study found that even in health plans where medications are free, rates of non-adherence were nearly 40%.  With the drug industry facing a huge loss of revenue from patent expiration you would figure that drug industry and the government would work to decrease non-adherence rates but they just can’t see the ROI clear enough. Continue reading »